Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholestyramine add-on to esomeprazole for post-ESD gastric ulcer healing
jRCTs031200235Completed
- Start
- Mar 2021
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of cholestyramine in gastric ulcer (2 arms). Primary endpoint: Rate of ulcer healing at 4–5 weeks after ESD. Started Mar 2021; status: completed.
02
Drugs
cholestyramine
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on jRCTs031200235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200235.